Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept

NCT00317538 is registered in ClinicalTrials.gov with Centocor Ortho Biotech Services, L.L.C. as lead sponsor.

NCT NCT00317538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00317538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
Lead sponsor
Centocor Ortho Biotech Services, L.L.C.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
November 30, 2004
Enrollment
28 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis